Works matching IS 09255710 AND DT 2021 AND VI 113 AND IP 2


Results: 21
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR.

    Published in:
    International Journal of Hematology, 2021, v. 113, n. 2, p. 219, doi. 10.1007/s12185-020-03013-6
    By:
    • Takezako, Naoki;
    • Shibayama, Hirohiko;
    • Handa, Hiroshi;
    • Hagiwara, Shotaro;
    • Ozaki, Shuji;
    • Suzuki, Kenshi;
    • Kosugi, Hiroshi;
    • Ri, Masaki;
    • Sugiura, Isamu;
    • Choi, Ilseung;
    • Miyamoto, Toshihiro;
    • Iida, Shinsuke
    Publication type:
    Article
    12
    13
    14
    15
    16

    Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.

    Published in:
    International Journal of Hematology, 2021, v. 113, n. 2, p. 285, doi. 10.1007/s12185-020-03006-5
    By:
    • Oya, Shuki;
    • Morishige, Satoshi;
    • Ozawa, Hidetoshi;
    • Sasaki, Kensuke;
    • Semba, Yuichiro;
    • Yamasaki, Yoshitaka;
    • Nakamura, Takayuki;
    • Aoyama, Kazutoshi;
    • Seki, Ritsuko;
    • Mouri, Fumihiko;
    • Osaki, Koichi;
    • Miyamoto, Toshihiro;
    • Maeda, Takahiro;
    • Nagafuji, Koji
    Publication type:
    Article
    17
    18
    19
    20

    The clonal evolution during long-term clinical course of multiple myeloma.

    Published in:
    International Journal of Hematology, 2021, v. 113, n. 2, p. 279, doi. 10.1007/s12185-020-02979-7
    By:
    • Mishima, Yuko;
    • Mishima, Yuji;
    • Shirouchi, Yuko;
    • Nishimura, Noriko;
    • Yokoyama, Masahiro;
    • Okabe, Takashi;
    • Inoue, Norihito;
    • Uryu, Hideki;
    • Fukuta, Takanori;
    • Hatake, Kiyohiko;
    • Terui, Yasuhito
    Publication type:
    Article
    21